ZFIN ID: ZDB-EXP-260413-2
Experiment Conditions Description: cold damage: heart, chemical treatment by environment: doxycycline, chemical treatment by environment: LDN-193189
cold damage: heart
Name: cold damage
Synonyms:
Definition: Physical alteration which uses cold to damage an anatomical structure, cell, or organ
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000248]
Name: heart
Synonyms:
Definition: Blood pumping organ composed of four components: sinus venosus, atrium, cardiac ventricle and bulbus arteriosus.
Ontology: Anatomy Ontology [ZFA:0000114]
chemical treatment by environment: doxycycline
Name: chemical treatment by environment
Synonyms:
Definition: Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000238]
Name: doxycycline
Synonyms: (4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE, 5-hydroxy-alpha-6-deoxytetracycline, 6alpha-deoxy-5-oxytetracycline, doxiciclina, Doxycyclin, Doxycycline, doxycycline (anhydrous), doxycyclinum, Jenacyclin, Supracyclin, Vibramycin
Definition: Tetracycline in which the 5β-hydrogen is replaced by a hydroxy group, while the 6α-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis.
Ontology: ChEBI [CHEBI:50845]  ( EBI )
chemical treatment by environment: LDN-193189
Name: chemical treatment by environment
Synonyms:
Definition: Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water.
Ontology: Zebrafish Environment Condition Ontology [ZECO:0000238]
Name: LDN-193189
Synonyms: LDN 193189, LDN193189
Definition: LDN193189 is a potent selective BMP type I receptor (BMP I) inhibitor. LDN-193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN-193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva.
Ontology: ChEBI [CHEBI:747377]  ( EBI )
Publication: Fang et al., 2020